HDIM
GOSS icon

Hanson & Doremus Investment Management’s Gossamer Bio GOSS Stock Holding History

Hanson & Doremus Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-459
Closed -$5K – 437
2020
Q1 		$5K Hold
459
– – ﹤0.01% 417
2019
Q4 		$7K Buy
459
+319
+228% +$6.42K ﹤0.01% 416
2019
Q3 		$2K Hold
140
– – ﹤0.01% 441
2019
Q2 		$3K Hold
140
– – ﹤0.01% 458
2019
Q1 		$3K Buy
+140
New +$2.92K ﹤0.01% 433

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Hanson & Doremus Investment Management's GOSS Position: Q2 2020 in Review

Hanson & Doremus Investment Management sold out of Gossamer Bio (GOSS) in Q2 2020, closing a stake of 459 shares — an estimated $5K sold.

Hanson & Doremus Investment Management first reported a position in GOSS in Q1 2019 and held it in 5 quarters. The position peaked at $7K in Q4 2019. 110 funds tracked by Wall St. Rank hold GOSS as of Q2 2020.

  • Hanson & Doremus Investment Management reported no remaining Gossamer Bio position as of Q2 2020 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 459 Gossamer Bio shares in Q2 2020, an estimated $5K.
  • Hanson & Doremus Investment Management first reported a position in Gossamer Bio in Q1 2019 and held it in 5 quarters.
  • Hanson & Doremus Investment Management's Gossamer Bio position peaked at $7K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2020.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2020, filed 17 Jul 2020.